Metabolic effects of the incretin mimetic exenatide in the treatment of type 2 diabetes
Catherine A Schnabel, Matthew Wintle, Orville KoltermanAmylin Pharmaceuticals, Inc, 9360 Towne Centre Drive, Suite 110, San Diego, CA 92121, USAAbstract: Interventional studies have demonstrated the impact of hyperglycemia on the development of vascular complications associated with type 2 diabetes,...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2006-03-01
|
| Series: | Vascular Health and Risk Management |
| Online Access: | https://www.dovepress.com/metabolic-effects-of-the-incretin-mimetic-exenatide-in-the-treatment-o-peer-reviewed-article-VHRM |